Last updated: June 13, 2025
Sponsor: Technical University of Munich
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Diabetes Prevention
Treatment
4g of taurine daily
Placebo
Clinical Study ID
NCT06613542
2024-253-S-CB
Ages 55-75 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
women or men
Age 55 - 75
BMI 22 - 30 kg/m²
written consent
Exclusion
Exclusion Criteria:
Acute or chronic inflammation (e.g. flu infection)
Severe chronic illness (e.g., Type 1 or Type 2 diabetes mellitus, COPD, renalinsufficiency)
Myocardial infarction or stroke in the previous 6 months
Psychiatric disorder, including depression or dementia
Weight change of ≥ 5 kg in the last 6 months
Study Design
Total Participants: 80
Treatment Group(s): 2
Primary Treatment: 4g of taurine daily
Phase:
Study Start date:
September 25, 2024
Estimated Completion Date:
November 30, 2025
Study Description
Connect with a study center
Institute for Nutritional Medicine of Technical University of Munich
Munich, 80992
GermanySite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.